Aktiesnakken — December 2019
-
Bloomberg
@business
·
8 min
2019 was among the best for European markets of the past two decades. Here's why a 2020 repeat is unlikelyhttps://www.bloomberg.com/news/articles/2019-12-17/here-are-a-few-things-to-worry-about-for-next-year-taking-stock-k49jd0ak?utm_campaign=socialflow-organic&cmpid=socialflow-twitter-business&utm_source=twitter&utm_content=business&utm_medium=social -
Onsdagens Vigtigste Nøgletal & Regnskaber: https://www.proinvestor.com/investornyt/651515/onsdagens-vigtigste-noslashgletal-amp-regnskaber
-
God morgen.

-
Nikkei 225 i Tokyo ned 0,4 prosent
Hang Seng i Hongkong ned 0,08 prosent
Kospi i Seoul opp ned 0,12 prosent
Shanghai Composite ned 0,08 prosent
Singapore-børsen opp 0,26 prosent
ASX 200 i Sydney opp 0,12 prosent -
S&P Futures -0.2%, Brent -0.2%
-
-
Orphazyme får eftertragtet status hos FDA til Arimoclomol
-
waturu i 40 nu ned med 60% på en uge....Og faldet stopper ikke der. Den er stadig massivt overvurderet
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind